{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:47:41Z","timestamp":1761896861746,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Thai Society of Hematology, Thailand,"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clml.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T12:19:52Z","timestamp":1533730792000},"page":"e509-e514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG"],"prefix":"10.1016","volume":"18","author":[{"given":"Weerapat","family":"Owattanapanich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eakkapol","family":"Utchariyaprasit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-9292","authenticated-orcid":false,"given":"Adisak","family":"Tantiworawit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekarat","family":"Rattarittamrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teeraya","family":"Puavilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirun","family":"Saelue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantiya","family":"Chanswangphuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1451-7636","authenticated-orcid":false,"given":"Wasithep","family":"Limvorapitak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonglak","family":"Kanitsap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinadol","family":"Wanitpongpun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chajchawan","family":"Nakhakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantarapa","family":"Sriswasdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kannadit","family":"Prayongratana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.31296","article-title":"Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California","volume":"124","author":"Ho","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/blood.V126.23.217.217","volume":"126","author":"Foran","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","article-title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1182\/blood-2012-06-436055","article-title":"Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia","volume":"120","author":"Quintas-Cardama","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","article-title":"Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia","volume":"30","author":"Kantarjian","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood-2013-12-540971","article-title":"Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine\/daunorubicin, vs cytarabine\/daunorubicin in older adults with untreated AML","volume":"123","author":"Lancet","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/10428194.2017.1330956","article-title":"Acute myeloid leukemia in the elderly: therapeutic options and choice","volume":"59","author":"Webster","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/asheducation-2016.1.339","article-title":"Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction","volume":"2016","author":"Rao","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1200\/JCO.2006.10.2731","article-title":"Acute myeloid leukemia and myelodysplastic syndromes in older patients","volume":"25","author":"Estey","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7314\/APJCP.2014.15.2.895","article-title":"Cytogenetic and genetic mutation features of de novo acute myeloid leukemia in elderly Chinese patients","volume":"15","author":"Su","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","article-title":"The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial","volume":"98","author":"Grimwade","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cancergen.2011.06.003","article-title":"A\u00a0single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia\u2014evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients","volume":"204","author":"So","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.clml.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.leu.2401638","article-title":"Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases","volume":"14","author":"Nakase","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.18632\/oncotarget.23823","article-title":"A\u00a0multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine","volume":"9","author":"Yi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/cncr.22976","article-title":"Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia","volume":"110","author":"Baz","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11899-017-0388-8","article-title":"Patterns of care and survival for elderly acute myeloid leukemia\u2014challenges and opportunities","volume":"12","author":"Mangaonkar","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.clml.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdy030","article-title":"Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients","volume":"29","author":"R\u00f6llig","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00432-017-2429-z","article-title":"Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis","volume":"143","author":"Zhang","year":"2017","journal-title":"J\u00a0Cancer Res Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018305597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018305597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:13Z","timestamp":1761870673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018305597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2152265018305597"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.08.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}